Actavis to Acquire Allergan to Create Top 10 Global Growth Pharmaceutical Company with $23 Billion in Revenue

From NeurologyWire

Actavis plc (NYSE: ACT) and Allergan, Inc. (NYSE: AGN) today announced that they have entered into a definitive agreement under which Actavis will acquire Allergan for a combination of $129.22 in cash and 0.3683 Actavis shares for each share of Allergan common stock. Based on the closing price of Actavis shares on November 14, 2014, the transactio...

Read full article

Wednesday, December 17, 2014

Show last days of articles

Meth Users Face Higher Risk for Developing Parkinsons Diseas...

From NeurologyWire

In addition to incurring serious dental problems, memory loss and other physical and mental issues, methamphetamine users are three times more at risk...Full story

Depression in dementia more common in community care, study ...

From NeurologyWire

A University of Manchester study of over 400 people in eight EU countries with severe dementia has found that those residing in long-term care homes a...Full story

Tuesday, December 16, 2014

Research Finds Nerve Damage in Patients with Fibromyalgia

From NeurologyWire

Therapath, LLC, a neuropathology laboratory services, reports that new findings have revealed that patients diagnosed with fibromyalgia may also have ...Full story

Monday, December 15, 2014

FDA Clears Olympus' Narrow Band Imaging (NBI) for Effective ...

From NeurologyWire

Olympus Medical Systems Group announced FDA 510(k) clearance of Narrow Band Imaging (NBI) as enabling effective targeting of biopsies not seen under w...Full story

Clinatec Chairman Alim-Louis Benabid Receives Lifetime Achie...

From NeurologyWire

Prof. Alim-Louis Benabid, board chairman of Clinatec - The Edmond J. Safra Biomedical Research Center, received the Lifetime Achievement award on Dec....Full story

Friday, December 12, 2014

Sleep Researchers Offer Suggestion: Start Work Day Later

From NeurologyWire

A new study in the December issue of Sleep shows that paid work time is the primary waking activity exchanged for sleep and suggests that chronic slee...Full story

Judge Orders Actavis to Continue Selling the Namenda Alzheim...

From NeurologyWire

A federal court judge has issued a preliminary injunction that prevents drug maker Actavis from pulling an older version of the Alzheimers Namenda fro...Full story

Thursday, December 11, 2014

Angiochem Publishes Data On ANG4043, A Brain-Penetrant Anti-...

From NeurologyWire

Angiochem, a clinical stage biotechnology company creating and developing drugs that cross the blood-brain barrier, announced the publication in Molec...Full story

Tuesday, December 09, 2014

New Assessment of Epilepsy Prevalence and Incidence

From NeurologyWire

There are 8.4 cases of epilepsy per 1,000 population, according to results from a new study presented at the 68th Annual Meeting of the American Epile...Full story

Promising Stroke Results Published

From NeurologyWire

The majority of patients who survive a stroke usually continue to suffer from permanent motor disorders (hemiparesis) or a linguistic handicap (aphasi...Full story

Monday, December 08, 2014

Optogenetics: Identifying New Targets for Epilepsy Intervent...

From NeurologyWire

Optogenetics is one of the hottest tools in biomedical research today, a method that uses gene therapy to deliver light-sensitive proteins into specif...Full story

Study Shows Link Between Cardiac Abnormalities, Sudden Unexp...

From NeurologyWire

Sudden death is more than 20 times more common in patients withepilepsy than in the general population. Defects in cardiac and respiratory function ar...Full story

Thursday, December 04, 2014

Tobacco Smoke Toxin Could Increase Pain in Spinal Cord Injur...

From NeurologyWire

A neurotoxin called acrolein found in tobacco smoke that is thought to increase pain in people with spinal cord injury has now been shown to accumulat...Full story

Preliminary Study Suggests Parkinson's Drugs Safe for the He...

From NeurologyWire

Non-ergot derived dopamine agonists used to treat Parkinson's disease may be safe for the heart, according to preliminary research presented at EuroEc...Full story

Wednesday, December 03, 2014

TBI Can Disrupt Glymphatic System and Accelerate Dementia

From NeurologyWire

A new study out today in the Journal of Neuroscience shows that traumatic brain injury can disrupt the function of the brains waste removal system. Wh...Full story